173 related articles for article (PubMed ID: 11779867)
1. Covalent attachment of the SUMO-1 protein to the negative regulatory domain of the c-Myb transcription factor modifies its stability and transactivation capacity.
Bies J; Markus J; Wolff L
J Biol Chem; 2002 Mar; 277(11):8999-9009. PubMed ID: 11779867
[TBL] [Abstract][Full Text] [Related]
2. Stress-induced inactivation of the c-Myb transcription factor through conjugation of SUMO-2/3 proteins.
Sramko M; Markus J; Kabát J; Wolff L; Bies J
J Biol Chem; 2006 Dec; 281(52):40065-75. PubMed ID: 17077080
[TBL] [Abstract][Full Text] [Related]
3. A functional SUMO-interacting motif in the transactivation domain of c-Myb regulates its myeloid transforming ability.
Saether T; Pattabiraman DR; Alm-Kristiansen AH; Vogt-Kielland LT; Gonda TJ; Gabrielsen OS
Oncogene; 2011 Jan; 30(2):212-22. PubMed ID: 20802522
[TBL] [Abstract][Full Text] [Related]
4. Sterol regulatory element-binding proteins are negatively regulated through SUMO-1 modification independent of the ubiquitin/26 S proteasome pathway.
Hirano Y; Murata S; Tanaka K; Shimizu M; Sato R
J Biol Chem; 2003 May; 278(19):16809-19. PubMed ID: 12615929
[TBL] [Abstract][Full Text] [Related]
5. Transactivation properties of c-Myb are critically dependent on two SUMO-1 acceptor sites that are conjugated in a PIASy enhanced manner.
Dahle Ø; Andersen TØ; Nordgård O; Matre V; Del Sal G; Gabrielsen OS
Eur J Biochem; 2003 Mar; 270(6):1338-48. PubMed ID: 12631292
[TBL] [Abstract][Full Text] [Related]
6. A SUMO-regulated activation function controls synergy of c-Myb through a repressor-activator switch leading to differential p300 recruitment.
Molvaersmyr AK; Saether T; Gilfillan S; Lorenzo PI; Kvaløy H; Matre V; Gabrielsen OS
Nucleic Acids Res; 2010 Aug; 38(15):4970-84. PubMed ID: 20385574
[TBL] [Abstract][Full Text] [Related]
7. A non-covalent interaction between small ubiquitin-like modifier-1 and Zac1 regulates Zac1 cellular functions.
Liu ST; Chang YL; Wang WM; Chung MH; Lin WS; Chou WY; Huang SM
Int J Biochem Cell Biol; 2012 Mar; 44(3):547-55. PubMed ID: 22227369
[TBL] [Abstract][Full Text] [Related]
8. Stress-induced phosphorylation of Thr486 in c-Myb by p38 mitogen-activated protein kinases attenuates conjugation of SUMO-2/3.
Bies J; Sramko M; Wolff L
J Biol Chem; 2013 Dec; 288(52):36983-93. PubMed ID: 24257756
[TBL] [Abstract][Full Text] [Related]
9. A synergy control motif within the attenuator domain of CCAAT/enhancer-binding protein alpha inhibits transcriptional synergy through its PIASy-enhanced modification by SUMO-1 or SUMO-3.
Subramanian L; Benson MD; Iñiguez-Lluhí JA
J Biol Chem; 2003 Mar; 278(11):9134-41. PubMed ID: 12511558
[TBL] [Abstract][Full Text] [Related]
10. Small ubiquitin-related modifier-1 (SUMO-1) modification of the glucocorticoid receptor.
Tian S; Poukka H; Palvimo JJ; Jänne OA
Biochem J; 2002 Nov; 367(Pt 3):907-11. PubMed ID: 12144530
[TBL] [Abstract][Full Text] [Related]
11. The DNA topoisomerase I binding protein topors as a novel cellular target for SUMO-1 modification: characterization of domains necessary for subcellular localization and sumolation.
Weger S; Hammer E; Engstler M
Exp Cell Res; 2003 Oct; 290(1):13-27. PubMed ID: 14516784
[TBL] [Abstract][Full Text] [Related]
12. Transcription factor AP-2 interacts with the SUMO-conjugating enzyme UBC9 and is sumolated in vivo.
Eloranta JJ; Hurst HC
J Biol Chem; 2002 Aug; 277(34):30798-804. PubMed ID: 12072434
[TBL] [Abstract][Full Text] [Related]
13. Post-translational modification of POU domain transcription factor Oct-4 by SUMO-1.
Zhang Z; Liao B; Xu M; Jin Y
FASEB J; 2007 Oct; 21(12):3042-51. PubMed ID: 17496161
[TBL] [Abstract][Full Text] [Related]
14. A Kruppel zinc finger of ZNF 146 interacts with the SUMO-1 conjugating enzyme UBC9 and is sumoylated in vivo.
Antoine K; Prosperi MT; Ferbus D; Boule C; Goubin G
Mol Cell Biochem; 2005 Mar; 271(1-2):215-23. PubMed ID: 15881673
[TBL] [Abstract][Full Text] [Related]
15. Post-translational modification of Rta of Epstein-Barr virus by SUMO-1.
Chang LK; Lee YH; Cheng TS; Hong YR; Lu PJ; Wang JJ; Wang WH; Kuo CW; Li SS; Liu ST
J Biol Chem; 2004 Sep; 279(37):38803-12. PubMed ID: 15229220
[TBL] [Abstract][Full Text] [Related]
16. Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor.
Ledl A; Schmidt D; Müller S
Oncogene; 2005 May; 24(23):3810-8. PubMed ID: 15806172
[TBL] [Abstract][Full Text] [Related]
17. c-Jun and p53 activity is modulated by SUMO-1 modification.
Muller S; Berger M; Lehembre F; Seeler JS; Haupt Y; Dejean A
J Biol Chem; 2000 May; 275(18):13321-9. PubMed ID: 10788439
[TBL] [Abstract][Full Text] [Related]
18. SUMO modification regulates MafB-driven macrophage differentiation by enabling Myb-dependent transcriptional repression.
Tillmanns S; Otto C; Jaffray E; Du Roure C; Bakri Y; Vanhille L; Sarrazin S; Hay RT; Sieweke MH
Mol Cell Biol; 2007 Aug; 27(15):5554-64. PubMed ID: 17548468
[TBL] [Abstract][Full Text] [Related]
19. In vitro modification of human centromere protein CENP-C fragments by small ubiquitin-like modifier (SUMO) protein: definitive identification of the modification sites by tandem mass spectrometry analysis of the isopeptides.
Chung TL; Hsiao HH; Yeh YY; Shia HL; Chen YL; Liang PH; Wang AH; Khoo KH; Shoei-Lung Li S
J Biol Chem; 2004 Sep; 279(38):39653-62. PubMed ID: 15272016
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the Ets-1 transcription factor by sumoylation and ubiquitinylation.
Ji Z; Degerny C; Vintonenko N; Deheuninck J; Foveau B; Leroy C; Coll J; Tulasne D; Baert JL; Fafeur V
Oncogene; 2007 Jan; 26(3):395-406. PubMed ID: 16862185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
